BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 17885521)

  • 1. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
    Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
    J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
    McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
    Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Kirma C; Dundar C; Pala S; Isiklar I; Cevik C; Kilicgedik A; Basaran Y
    J Am Soc Echocardiogr; 2010 Apr; 23(4):416-22. PubMed ID: 20149594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy.
    Akisawa M; Matsumura Y; Kitaoka H; Yamasaki N; Takata J; Doi Y
    J Cardiol; 2002 Oct; 40(4):145-52. PubMed ID: 12420668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of transmural extent of infarction with contrast echocardiographically derived index of myocardial blood flow and myocardial blood volume fraction: comparison with contrast-enhanced magnetic resonance imaging.
    Choi EY; Seo HS; Park S; Kim HJ; Ahn JA; Ko YG; Choi BW; Kang SM; Choi D; Ha JW; Rim SJ; Jang Y; Chung N
    J Am Soc Echocardiogr; 2006 Oct; 19(10):1211-9. PubMed ID: 17000359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
    Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
    J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic cardiomyopathy: lack of clinical applicability of the WHO/ISFC classification of cardiomyopathies.
    Boffa GM; Tarantini G; Abbasciano A; Razzolini R; Chioin R; Thiene G
    Ital Heart J; 2001 Oct; 2(10):778-81. PubMed ID: 11721723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement.
    Jackson E; Bellenger N; Seddon M; Harden S; Peebles C
    Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study.
    Sueyoshi E; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Apr; 194(4):W293-8. PubMed ID: 20308473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy.
    Kaandorp TA; Bax JJ; Schuijf JD; Viergever EP; van Der Wall EE; de Roos A; Lamb HJ
    Am J Cardiol; 2004 Jun; 93(12):1461-4. PubMed ID: 15194013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of enhancement of left ventricular myocardium in patients with dilated cardiomyopathy using delayed enhanced MR imaging.
    Sueyoshi E; Sakamoto I; Hayashida T; Uetani M
    Comput Med Imaging Graph; 2009 Oct; 33(7):547-52. PubMed ID: 19545975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging is superior to cardiac scintigraphy to identify nonresponders to cardiac resynchronization therapy.
    Yokokawa M; Tada H; Toyama T; Koyama K; Naito S; Oshima S; Taniguchi K
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S57-62. PubMed ID: 19250113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Takotsubo cardiomyopathy or myocardial infarction? Answers from delayed enhancement magnetic resonance imaging.
    Eitel I; Behrendt F; Schindler K; Gutberlet M; Schuler G; Thiele H
    Int J Cardiol; 2009 Jun; 135(1):e9-12. PubMed ID: 18597873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.